Cite
MLA Citation
Erwin De Cock et al.. “A time and motion study of subcutaneous versus intravenous trastuzumab in patients with HER2‐positive early breast cancer.” Cancer medicine, vol. 5, n.d., pp. 389–397. http://access.bl.uk/ark:/81055/vdc_100031198114.0x000015